d) at Clairo

Hanover, Lower-Saxony, Germany

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Manufacturing, AutomotiveIndustries

Requirements

Abgeschlossene Ausbildung oder Studium im Bereich Automatisierungstechnik, Elektrotechnik, Mechatronik oder vergleichbar
Erfahrung in der SPS-Programmierung (z.B. S7 und TIA), Umgang mit industrieller Steuerungstechnik sowie in der Antriebstechnik (z.B. Servoantriebe)
Analytisches Denkvermögen und strukturierte Arbeitsweise
Gute Deutschkenntnisse in Wort und Schrift sowie grundlegende Englischkenntnisse zur Nutzung technischer Dokumentationen
Hohes Verantwortungsbewusstsein, Organisationsfähigkeit, sicheres Auftreten und Kommunikationsstärke

Responsibilities

Mitwirkung bei der Optimierung von Automatisierungs- und Steuerungssystemen zur Effizienzsteigerung in der Produktion
Installation, Inbetriebnahme und Wartung der Steuerungstechnik
Programmierung und Anpassung von Steuerungen (z.B. Siemens) sowie Unterstützung bei der Implementierung neuer Softwarelösungen
Analyse, Fehlerdiagnose und Behebung von Störungen zur Sicherstellung eines reibungslosen Produktionsablaufs
Mitarbeit in interdisziplinären Projekten zur technischen Prozessoptimierung
Erstellung technischer Dokumentationen und Bearbeitung technischer Fragestellungen

Skills

PLC Programming

Siemens S7

TIA Portal

Servo Drives

Automation Systems

Control Technology

Drive Technology

Fault Diagnosis

Siemens PLC

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free